Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001731122-24-001290
Filing Date
2024-08-20
Accepted
2024-08-20 07:53:21
Documents
77
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q/A e5858_10qa.htm   iXBRL 10-Q/A 1506444
2 EXHIBIT 31.1 e5858_ex31-1.htm EX-31.1 8642
3 EXHIBIT 31.2 e5858_ex31-2.htm EX-31.2 8597
4 EXHIBIT 32.1 e5858_ex32-1.htm EX-32.1 4998
5 EXHIBIT 32.2 e5858_ex32-2.htm EX-32.2 5106
  Complete submission text file 0001731122-24-001290.txt   7962655

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE renb-20240331.xsd EX-101.SCH 65358
7 XBRL CALCULATION FILE renb-20240331_cal.xml EX-101.CAL 53483
8 XBRL DEFINITION FILE renb-20240331_def.xml EX-101.DEF 278622
9 XBRL LABEL FILE renb-20240331_lab.xml EX-101.LAB 475706
10 XBRL PRESENTATION FILE renb-20240331_pre.xml EX-101.PRE 425329
79 EXTRACTED XBRL INSTANCE DOCUMENT e5858_10qa_htm.xml XML 1184620
Mailing Address CENTURY CITY MEDICAL PLAZA 2080 CENTURY CITY EAST SUITE 906 LOS ANGELES CA 90067
Business Address CENTURY CITY MEDICAL PLAZA 2080 CENTURY CITY EAST SUITE 906 LOS ANGELES CA 90067 45 39179840
RENOVARO INC. (Filer) CIK: 0001527728 (see all company filings)

EIN.: 452259340 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q/A | Act: 34 | File No.: 001-38758 | Film No.: 241222676
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)